Gemcitabine + carboplatin (urothelial carcinoma, cisplatin-ineligible)
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Components | DRUG-GEMCITABINE DRUG-CARBOPLATIN |
|---|
| ID | REG-GEM-CARBO-UROTHELIAL |
|---|---|
| Type | Regimen |
| Status | reviewed 2026-05-04 | pending_clinical_signoff |
| Diseases | None declared |
| Sources | SRC-NCCN-BLADDER-2025 |
Used By
Algorithms
ALGO-UROTHELIAL-METASTATIC-2L- ALGO-UROTHELIAL-METASTATIC-2L
Indication
IND-UROTHELIAL-2L-PLATINUM-CHEMO- IND-UROTHELIAL-2L-PLATINUM-CHEMO